BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 15264997)

  • 1. Tiotropium bromide, a new, once-daily inhaled anticholinergic bronchodilator for chronic-obstructive pulmonary disease.
    ZuWallack AR; ZuWallack RL
    Expert Opin Pharmacother; 2004 Aug; 5(8):1827-35. PubMed ID: 15264997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
    Keam SJ; Keating GM
    Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tiotropium bromide: a novel once-daily anticholinergic bronchodilator for the treatment of COPD.
    Hansel TT; Barnes PJ
    Drugs Today (Barc); 2002 Sep; 38(9):585-600. PubMed ID: 12582447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of combining olodaterol Respimat(®) and tiotropium HandiHaler(®) in patients with COPD: results of two randomized, double-blind, active-controlled studies.
    ZuWallack R; Allen L; Hernandez G; Ting N; Abrahams R
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1133-44. PubMed ID: 25342898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease.
    Casaburi R; Mahler DA; Jones PW; Wanner A; San PG; ZuWallack RL; Menjoge SS; Serby CW; Witek T
    Eur Respir J; 2002 Feb; 19(2):217-24. PubMed ID: 11866001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease.
    van Noord JA; Smeets JJ; Custers FL; Korducki L; Cornelissen PJ
    Eur Respir J; 2002 Apr; 19(4):639-44. PubMed ID: 11998992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of dual therapy with GSK233705 and salmeterol versus monotherapy with salmeterol, tiotropium, or placebo in a crossover pilot study in partially reversible COPD patients.
    Beier J; van Noord J; Deans A; Brooks J; Maden C; Baggen S; Mehta R; Cahn A
    Int J Chron Obstruct Pulmon Dis; 2012; 7():153-64. PubMed ID: 22419863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tiotropium bromide: a new long-acting bronchodilator for the treatment of chronic obstructive pulmonary disease.
    Koumis T; Samuel S
    Clin Ther; 2005 Apr; 27(4):377-92. PubMed ID: 15922812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tiotropium bromide inhalation powder: a review of its use in the management of chronic obstructive pulmonary disease.
    Keating GM
    Drugs; 2012 Jan; 72(2):273-300. PubMed ID: 22217233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tiotropium (Spiriva) - a long-acting inhaled anticholinergic for the treatment of chronic obstructive pulmonary disease (COPD)].
    Beeh KM; Welte T; Buhl R
    Pneumologie; 2003 Sep; 57(9):519-25. PubMed ID: 13680472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tiotropium versus placebo for chronic obstructive pulmonary disease.
    Karner C; Chong J; Poole P
    Cochrane Database Syst Rev; 2012 Jul; (7):CD009285. PubMed ID: 22786525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease.
    Farne HA; Cates CJ
    Cochrane Database Syst Rev; 2015 Oct; (10):CD008989. PubMed ID: 26490945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease.
    Cheyne L; Irvin-Sellers MJ; White J
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009552. PubMed ID: 26391969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aclidinium bromide for stable chronic obstructive pulmonary disease.
    Ni H; Soe Z; Moe S
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD010509. PubMed ID: 25234126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of once-daily QVA149 compared with the free combination of once-daily tiotropium plus twice-daily formoterol in patients with moderate-to-severe COPD (QUANTIFY): a randomised, non-inferiority study.
    Buhl R; Gessner C; Schuermann W; Foerster K; Sieder C; Hiltl S; Korn S
    Thorax; 2015 Apr; 70(4):311-9. PubMed ID: 25677679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease.
    Cheyne L; Irvin-Sellers MJ; White J
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009552. PubMed ID: 24043433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of tiotropium bromide, a long-acting anticholinergic bronchodilator, in the management of COPD.
    Saberi F; O'Donnell DE
    Treat Respir Med; 2005; 4(4):275-81. PubMed ID: 16086600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tiotropium versus placebo for chronic obstructive pulmonary disease.
    Karner C; Chong J; Poole P
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD009285. PubMed ID: 25046211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tiotropium bromide.
    Barnes PJ
    Expert Opin Investig Drugs; 2001 Apr; 10(4):733-40. PubMed ID: 11281822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tiotropium bromide.
    Hvizdos KM; Goa KL
    Drugs; 2002; 62(8):1195-203; discussion 1204-5. PubMed ID: 12010082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.